Doubts are mounting over the Labour government’s flagship growth and investment agenda, with one analyst warning further tax rises could be on the horizon.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.